Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-23T21:19:26.243Z Has data issue: false hasContentIssue false
  • English
  • Français

Treatment of Neuroleptic Malignant Syndrome

Published online by Cambridge University Press:  29 January 2018

P. D. White
P. D. White*
Affiliation:
King's College Hospital, Denmark Hill, Camberwell, London SE5 9RS
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
The British Journal of Psychiatry , Volume 144 , Issue 4 , April 1984 , pp. 437
Copyright
Copyright © 1984 The Royal College of Psychiatrists 

References

Crow, T. J. (1980) Molecular pathology of schizophrenia: more than one disease process? British Medical Journal, 280, 66–8.CrossRefGoogle ScholarPubMed
Granato, J. E., Stern, B. J., Ringel, A., Karim, A. H., Krumholz, A., Coyle, J. & Adler, S. (1983) Neuroleptic malignant syndrome: successful treatment with dantrolene and bromocriptine. Annals of Neurology, 14, 89–90.Google Scholar
Marsden, C. D. & Jenner, P. (1980) The pathophysiology of extrapyramidal side-effects of neuroleptic drugs. Psychological Medicine, 10, 55–72.Google Scholar
Mueller, P. S., Vester, J. W. & Fermaglich, J. (1983) Neuroleptic malignant syndrome: successful treatment with bromocriptine. Journal of the American Medical Association, 249, 386–8.Google ScholarPubMed
White, P. D. (1983) Neuroleptic malignant syndrome. British Medical Journal, 287, 561.Google Scholar
Zubenko, G. & Pope, H. G. (1983) Management of a case of neuroleptic malignant syndrome with bromocriptine. American Journal of Psychiatry, 140, 1619–20.Google ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.